TAF6L (TATA-box binding protein associated factor 6-like) operates within the intricate framework of the cell's transcriptional machinery. The suite of chemicals known to influence this protein spans a wide spectrum, aiming at various cellular processes which subsequently cascade to modulate the activity or function of TAF6L. Among these, adenylate cyclase activators, such as Forskolin and 8-Br-cAMP, are noteworthy. Their function leads to an elevation of cAMP levels, which in turn stimulates PKA, a kinase that can perturb the balance and dynamics of transcriptional machinery, thereby influencing TAF6L's role.
The broader protein kinase landscape is also rife with agents like PMA, Staurosporine, and Y-27632, each targeting distinct kinases that are intertwined with transcriptional regulation. For instance, PMA's activation of PKC and Y-27632's inhibition of ROCK can both reverberate through the cell, adjusting the transcriptional dynamics and, by extension, modulating TAF6L's function. Similarly, calcium ionophores, Ionomycin and A-23187, spotlight calcium's essential role in myriad cellular processes, including transcription. Elevated intracellular calcium can induce a series of events leading to potential shifts in the transcriptional landscape, indirectly affecting TAF6L. Compounds like Rapamycin and U0126 underline the importance of well-known cellular pathways, such as mTOR and MEK respectively. Their perturbation of these pathways sheds light on the vast interconnectedness of cellular processes, where a change in one pathway can have cascading effects on the transcriptional mechanisms and components, including TAF6L.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Direct activator of adenylate cyclase, which increases cAMP levels. Elevated cAMP activates PKA, which can modulate transcriptional machinery, influencing TAF6L activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cell-permeable cAMP analog. By increasing cAMP levels, it can enhance PKA activity, subsequently affecting TAF6L as part of the transcriptional apparatus. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activator of protein kinase C (PKC). PKC activation modulates transcriptional machinery dynamics and can thereby influence TAF6L's role. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Protein phosphatase inhibitor. By altering phosphorylation dynamics, Calyculin A can modulate transcriptional complexes in which TAF6L functions. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore. Intracellular calcium surges can influence numerous pathways, including those related to transcription where TAF6L is involved. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore. By modulating intracellular calcium, it can indirectly affect TAF6L's role in transcription processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR pathway inhibitor. As mTOR regulates transcriptional activity, its inhibition can indirectly modulate TAF6L's functionality. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Rho-associated kinase (ROCK) inhibitor. ROCK has a role in transcriptional regulation and its inhibition can indirectly influence TAF6L. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Broad-spectrum protein kinase inhibitor. Influencing general kinase activity can have cascading effects on transcriptional machinery, including TAF6L. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Non-muscle myosin II ATPase activity inhibitor. As myosin is implicated in nuclear positioning, its inhibition can indirectly modulate transcription processes involving TAF6L. | ||||||